3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Uterine Cervical Neoplasms
7
Prostatic Neoplasms
6
Vaginal Neoplasms
2
Breast Neoplasms
2
Sarcoma
1
Rhabdomyosarcoma
1
Retinoblastoma
1
Prostatic Diseases
1
Parkinson Disease 4, Autosomal Dominant Lewy Body
1
Locally Advanced Cervical Adenocarcinoma
1
Gynecologic Cancer
1
Esophageal Neoplasms
1
Endometrial Neoplasms
1
Carcinosarcoma
1
Carcinoma, Hepatocellular
1
Carcinoma, Ductal, Breast
1
Carcinoma, Ductal
1
Interventions
X-Rays
6
Phantoms, Imaging
6
Magnetic Resonance Spectroscopy
6
Specimen Handling
5
Nuclear Medicine Department, Hospital
5
Biopsy
4
ulixertinib
2
tipifarnib
2
tazemetostat
2
selpercatinib
2
palbociclib
2
larotrectinib
2
ivosidenib
2
erdafitinib
2
ensartinib
2
LY3023414
2
talazoparib
1
olaparib
1
irinotecan sucrosofate
1
amino-acid, glucose, and electrolyte solution
1
Vemurafenib
1
Temozolomide
1
Pharmacogenomic Variants
1
Liquid Biopsy
1
177Lu-octreotide, DOTA(0)-Tyr(3)-
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Neuroectodermal Tumors, Primitive, Peripheral
×
Brachytherapy
×
90 days
×
Clear all
No trials found.